WMA Declaration of Helsinki – Ethical Principles f... ...
Mark Cuban: A Master Disrupter for American Health...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
Mark Cuban: A Master Disrupter for American Health...
Science in the Age of AI | AI for Science Forum...
WHO seeks $135 million to defeat mpox...
August 27,2024 0
AI-Powered Breakthrough: Novo Nordisk and Valo Health Expand...
January 09,2025 0
Study Warns: Common Antibiotics Can Trigger Severe Skin Reac...
August 13,2024 0
Scientists uncover genetic cause of rare autoimmune disorder...
October 09,2024 0
Why isn’t dental health considered primary medical care?...
August 17,2024 0
Reduced heart rate fluctuations due to disruption of the bod...
September 23,2024 0
Category
Oncology
Cardiology & Vascular Surgery
Gastroenterology
Pediatrics
Hematology&Oncology
Ophthalmology
Medicine
Plastic Surgery
Medical research
Sleep
Most Read
Study finds bone injections don't improve survival over IV in cardiac arrest treatment

Study finds bone injections don't improve survival over IV in cardiac arrest treatment

byUniversity of WarwickCredit: Pixabay/CC0 Public DomainAdministrating life-saving drugs for cardiac arrest directly into the bone does not improve survival rates compared to the standard intrav
Cardiovascular Diseases November 27,2024 0
Study finds bone injections don't improve survival over IV in cardiac arrest treatment

Study finds bone injections don't improve survival over IV in cardiac arrest treatment

byUniversity of WarwickCredit: Pixabay/CC0 Public DomainAdministrating life-saving drugs for cardiac arrest directly into the bone does not improve survival rates compared to the standard intrav
Cardiovascular Diseases November 27,2024 0
Science-2024 Breakthrough of the Year：The long shot

Science-2024 Breakthrough of the Year：The long shot

An innovative injectable HIV drug, lenacapavir, has shown significant effectiveness in preventing infections, offering a promising new breakthrough in the fight against the virus.
Medicial Breakthroughs December 13,2024 0
Science-2024 Breakthrough of the Year：The long shot

Science-2024 Breakthrough of the Year：The long shot

An innovative injectable HIV drug, lenacapavir, has shown significant effectiveness in preventing infections, offering a promising new breakthrough in the fight against the virus.
Medicial Breakthroughs December 13,2024 0
Today's News
Why is Alzheimer’s disease so difficult to treat? ...
Can a twice-a-year shot help end the HIV...
Reprogramming Stem Cells Could Cure Type...
Why are young, healthy adults experienci...
Why MDMA did NOT get FDA approval...
More News
New web portal empowers drug discovery, systems-level analysis of critical kinase-substrate interactions

New web portal empowers drug discovery, systems-level analysis of critical kinase-substrate interactions

byThe Mount Sinai HospitalKiNet functionalities. Credit:npj Systems Biology and Applications(2024). DOI: 10.1038/s41540-024-00442-5Researchers from the Icahn School of Medicine at Mo
Medical research October 21,2024 0
New web portal empowers drug discovery, systems-level analysis of critical kinase-substrate interactions

New web portal empowers drug discovery, systems-level analysis of critical kinase-substrate interactions

byThe Mount Sinai HospitalKiNet functionalities. Credit:npj Systems Biology and Applications(2024). DOI: 10.1038/s41540-024-00442-5Researchers from the Icahn School of Medicine at Mo
Medical research October 21,2024 0
Common diabetes drug shows promise for treating macular degeneration

Common diabetes drug shows promise for treating macular degeneration

byUniversity of Chicago Medical CenterMetformin 500mg tablets. Credit: public domainAge-related macular degeneration (AMD) is one of the leading causes of vision loss in adults over 50 in the Un
Ophthalmology October 21,2024 0
Common diabetes drug shows promise for treating macular degeneration

Common diabetes drug shows promise for treating macular degeneration

byUniversity of Chicago Medical CenterMetformin 500mg tablets. Credit: public domainAge-related macular degeneration (AMD) is one of the leading causes of vision loss in adults over 50 in the Un
Ophthalmology October 21,2024 0
New book explores the history of the phony cancer drug Krebiozen

New book explores the history of the phony cancer drug Krebiozen

by Sharita Forrest,University of Illinois at Urbana-ChampaignCredit: 3 Fields BooksIn March 1951, Andrew Ivy—at the time, one of the most renowned scientists and medical ethicists in the U.S.—he
Oncology October 21,2024 0
New book explores the history of the phony cancer drug Krebiozen

New book explores the history of the phony cancer drug Krebiozen

by Sharita Forrest,University of Illinois at Urbana-ChampaignCredit: 3 Fields BooksIn March 1951, Andrew Ivy—at the time, one of the most renowned scientists and medical ethicists in the U.S.—he
Oncology October 21,2024 0
Promising Alzheimer's drug candidate prevents buildup of tau proteins in lab and fruit fly studies

Promising Alzheimer's drug candidate prevents buildup of tau proteins in lab and fruit fly studies

byLancaster UniversityThe brain of a 7-day-old fruit fly with Tau expressed in a neuronal circuit used by the fly in olfactory memory. The green outlines the neurons, which are starting to swell
Neurology October 21,2024 0
Promising Alzheimer's drug candidate prevents buildup of tau proteins in lab and fruit fly studies

Promising Alzheimer's drug candidate prevents buildup of tau proteins in lab and fruit fly studies

byLancaster UniversityThe brain of a 7-day-old fruit fly with Tau expressed in a neuronal circuit used by the fly in olfactory memory. The green outlines the neurons, which are starting to swell
Neurology October 21,2024 0
Abortion pills will be controlled substances in Louisiana soon. Doctors have concerns

Abortion pills will be controlled substances in Louisiana soon. Doctors have concerns

by SARA CLINE and LAURA UNGARBottles of abortion pills mifepristone, left, and misoprostol, right, are displayed at a clinic in Des Moines, Iowa, Sept. 22, 2010. Credit: AP Photo/Charlie Neibergall, F
Obstetrics & Gynecology October 21,2024 0
Abortion pills will be controlled substances in Louisiana soon. Doctors have concerns

Abortion pills will be controlled substances in Louisiana soon. Doctors have concerns

by SARA CLINE and LAURA UNGARBottles of abortion pills mifepristone, left, and misoprostol, right, are displayed at a clinic in Des Moines, Iowa, Sept. 22, 2010. Credit: AP Photo/Charlie Neibergall, F
Obstetrics & Gynecology October 21,2024 0
Trial supports radiotherapy and cisplatin remaining as the standard of care for p16+ oropharyngeal cancer

Trial supports radiotherapy and cisplatin remaining as the standard of care for p16+ oropharyngeal cancer

by NRG OncologyCredit: Pixabay/CC0 Public DomainThe NRG Oncology NRG-HN005 phase II/III clinical trial has not met the non-inferiority criteria to proceed to the phase III portion of the study. The ph
ENT & HN Surgery October 21,2024 0
Trial supports radiotherapy and cisplatin remaining as the standard of care for p16+ oropharyngeal cancer

Trial supports radiotherapy and cisplatin remaining as the standard of care for p16+ oropharyngeal cancer

by NRG OncologyCredit: Pixabay/CC0 Public DomainThe NRG Oncology NRG-HN005 phase II/III clinical trial has not met the non-inferiority criteria to proceed to the phase III portion of the study. The ph
ENT & HN Surgery October 21,2024 0
Gilead licenses HIV-prevention drug to generic drugmakers

Gilead licenses HIV-prevention drug to generic drugmakers

Credit: Pixabay/CC0 Public DomainUS pharmaceutical giant Gilead said Wednesday it had signed licensing deals with six generic drugmakers to produce and sell its HIV prevention medicine in lower-income
Public Health & Prevention October 21,2024 0
Gilead licenses HIV-prevention drug to generic drugmakers

Gilead licenses HIV-prevention drug to generic drugmakers

Credit: Pixabay/CC0 Public DomainUS pharmaceutical giant Gilead said Wednesday it had signed licensing deals with six generic drugmakers to produce and sell its HIV prevention medicine in lower-income
Public Health & Prevention October 21,2024 0
Clinical trial: Addition of atezolizumab to standard care does not improve limited-stage small cell lung cancer survival

Clinical trial: Addition of atezolizumab to standard care does not improve limited-stage small cell lung cancer survival

by NRG OncologyCredit: Unsplash/CC0 Public DomainThe addition of the cancer immunotherapy drug atezolizumab to the standard of care concurrent chemoradiation (cCRT) did not improve overall survival fo
Oncology October 21,2024 0
Clinical trial: Addition of atezolizumab to standard care does not improve limited-stage small cell lung cancer survival

Clinical trial: Addition of atezolizumab to standard care does not improve limited-stage small cell lung cancer survival

by NRG OncologyCredit: Unsplash/CC0 Public DomainThe addition of the cancer immunotherapy drug atezolizumab to the standard of care concurrent chemoradiation (cCRT) did not improve overall survival fo
Oncology October 21,2024 0
Does psilocybin really provide long-term relief from depression, as new study suggests?

Does psilocybin really provide long-term relief from depression, as new study suggests?

by Johan Lundberg and Guusje Haver,The ConversationCredit: Unsplash/CC0 Public DomainPsilocybin, the psychedelic substance found in magic mushrooms, is a promising new treatment for psychiatric
Psychiatry & Mental Health October 21,2024 0
Does psilocybin really provide long-term relief from depression, as new study suggests?

Does psilocybin really provide long-term relief from depression, as new study suggests?

by Johan Lundberg and Guusje Haver,The ConversationCredit: Unsplash/CC0 Public DomainPsilocybin, the psychedelic substance found in magic mushrooms, is a promising new treatment for psychiatric
Psychiatry & Mental Health October 21,2024 0
FDA approves Dupixent for chronic obstructive pulmonary disease

FDA approves Dupixent for chronic obstructive pulmonary disease

by Lori SolomonThe U.S. Food and Drug Administration has approved Regeneron's Dupixent (dupilumab) as an add-on maintenance treatment for adults with inadequately controlled chronic obstructive pu
Pulmonology October 21,2024 0
FDA approves Dupixent for chronic obstructive pulmonary disease

FDA approves Dupixent for chronic obstructive pulmonary disease

by Lori SolomonThe U.S. Food and Drug Administration has approved Regeneron's Dupixent (dupilumab) as an add-on maintenance treatment for adults with inadequately controlled chronic obstructive pu
Pulmonology October 21,2024 0
More News
Week’s Top
Podcasts
... Breakthrough in Brain-Machine Interface: Chinese “Thought Communication” Becomes Reality Compared to decoding English’s 26 letters, decoding Chinese with its “418 syllables and 4 tones” presents a higher difficulty. ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu... ... Health spending has been rising across rich countries with different systems ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
APP
Medicine.net
Meditionary
PanWriting
PanDraw